212 related articles for article (PubMed ID: 28886363)
21. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
Ahmed MZ; Badani P; Reddy R; Mishra G
J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
[TBL] [Abstract][Full Text] [Related]
22. Battling CRISPR-Cas9 off-target genome editing.
Li D; Zhou H; Zeng X
Cell Biol Toxicol; 2019 Oct; 35(5):403-406. PubMed ID: 31313008
[No Abstract] [Full Text] [Related]
23. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Lareau CA; Clement K; Hsu JY; Pattanayak V; Joung JK; Aryee MJ; Pinello L
Nat Methods; 2018 Apr; 15(4):238-239. PubMed ID: 29600992
[No Abstract] [Full Text] [Related]
24. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Nutter LMJ; Heaney JD; Lloyd KCK; Murray SA; Seavitt JR; Skarnes WC; Teboul L; Brown SDM; Moore M
Nat Methods; 2018 Apr; 15(4):235-236. PubMed ID: 29600991
[No Abstract] [Full Text] [Related]
25. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Kim ST; Park J; Kim D; Kim K; Bae S; Schlesner M; Kim JS
Nat Methods; 2018 Apr; 15(4):239-240. PubMed ID: 29600990
[No Abstract] [Full Text] [Related]
26. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Wilson CJ; Fennell T; Bothmer A; Maeder ML; Reyon D; Cotta-Ramusino C; Fernandez CA; Marco E; Barrera LA; Jayaram H; Albright CF; Cox GF; Church GM; Myer VE
Nat Methods; 2018 Apr; 15(4):236-237. PubMed ID: 29600989
[No Abstract] [Full Text] [Related]
27. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Lescarbeau RM; Murray B; Barnes TM; Bermingham N
Nat Methods; 2018 Apr; 15(4):237. PubMed ID: 29600988
[No Abstract] [Full Text] [Related]
28. Evaluation of mutation rates, mosaicism and off target mutations when injecting Cas9 mRNA or protein for genome editing of bovine embryos.
Hennig SL; Owen JR; Lin JC; Young AE; Ross PJ; Van Eenennaam AL; Murray JD
Sci Rep; 2020 Dec; 10(1):22309. PubMed ID: 33339870
[TBL] [Abstract][Full Text] [Related]
29. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
[TBL] [Abstract][Full Text] [Related]
30. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
31. Epigenome editing by CRISPR/Cas9 in clinical settings: possibilities and challenges.
Pei WD; Zhang Y; Yin TL; Yu Y
Brief Funct Genomics; 2020 May; 19(3):215-228. PubMed ID: 31819946
[TBL] [Abstract][Full Text] [Related]
32. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
[TBL] [Abstract][Full Text] [Related]
33. [Research progress of CRISPR-Cas9 system for gene therapy].
Zhan C; Xia X
Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
[TBL] [Abstract][Full Text] [Related]
34. CRISPR system: Discovery, development and off-target detection.
Chen S; Yao Y; Zhang Y; Fan G
Cell Signal; 2020 Jun; 70():109577. PubMed ID: 32097710
[TBL] [Abstract][Full Text] [Related]
35. CRISPR/Cas: A powerful tool for gene function study and crop improvement.
Zhang D; Zhang Z; Unver T; Zhang B
J Adv Res; 2021 Mar; 29():207-221. PubMed ID: 33842017
[TBL] [Abstract][Full Text] [Related]
36. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
Meng X; Zhou H; Xu S
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
[TBL] [Abstract][Full Text] [Related]
37. Cas9HF1 enhanced specificity in Ustilago maydis.
Zuo W; Depotter JR; Doehlemann G
Fungal Biol; 2020; 124(3-4):228-234. PubMed ID: 32220383
[TBL] [Abstract][Full Text] [Related]
38. Base Editing: The Ever Expanding Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Tool Kit for Precise Genome Editing in Plants.
Monsur MB; Shao G; Lv Y; Ahmad S; Wei X; Hu P; Tang S
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32344599
[TBL] [Abstract][Full Text] [Related]
39. SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power.
Zhang D; Zhang B
Trends Genet; 2020 Aug; 36(8):546-548. PubMed ID: 32456805
[TBL] [Abstract][Full Text] [Related]
40. Making point mutations in Escherichia coli BL21 genome using the CRISPR-Cas9 system.
Wang X; He J; Le K
FEMS Microbiol Lett; 2018 Jul; 365(14):. PubMed ID: 29596631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
